Search

Your search keyword '"L-Leucovorin"' showing total 12 results

Search Constraints

Start Over You searched for: Descriptor "L-Leucovorin" Remove constraint Descriptor: "L-Leucovorin" Topic medicine Remove constraint Topic: medicine
12 results on '"L-Leucovorin"'

Search Results

1. P-271 Feasibility of neoadjuvant chemotherapy with modified FOLFOX6 (combination chemotherapy of infusional 5-FU/l-Leucovorin and intermittent oxaliplatin) with bevacizumab in patients with locally advanced lower rectal cancer

2. Pharmacodynamic study of the Saltz regimen for metastatic colorectal cancer in a hemodialyzed patient

3. 6012 The FIRIS study; A Phase III trial of 5-FU/l-leucovorin/irinotecan (FOLFIRI) versus irinotecan/S-1 (IRIS) as 2nd-line chemotherapy for metastatic colorectal cancer (mCRC) [FIRIS study group]

4. Retrospective Study of L-Leucovorin and 5-FU Therapy in Gastric Cancer with Severe Ascites or Inadequate Oral Intake

5. 6098 POSTER CRAFT Trial-Result From Multicenter Phase II Study of Modified FOLFOX7 (Combination Chemotherapy of Infusional 5-FU/l-Leucovorin and Intermittent Oxaliplatin) With Bevacizumab in the First-line Therapy of Colorectal Cancer

6. Updated results of the FIRIS study: A phase II/III trial of 5-FU/l-leucovorin/irinotecan (FOLFIRI) versus irinotecan/S-1 (IRIS) as second-line chemotherapy for metastatic colorectal cancer (mCRC)

7. Appropriate schedule of oral tegafur / uracil (UFT) in combination with irinotecan (CPT-11) and bolus 5-FU / l-leucovorin (LV) in patients (pts) with metastatic colorectal cancer (MCRC): A phase I study

8. A multicenter phase II study of irinotecan (CPT-11) and bolus 5-fluorouracil (5FU)/l-leucovorin (l-LV) in patients with metastatic colorectal cancer

9. A phase II trial of high-dose radiotherapy (60 Gy) and UFT/l-leucovorin in patients with locally advanced rectal cancer (LARC): Long-term results

10. Multicenter phase II study of irinotecan plus weekly bolus 5-FU and high dose l-leucovorin for patients with metastatic colorectal cancer (OGSG 0201)

11. Oxaliplatin (L-OHP) in combination with 5-fluorouracil (5-FU)/l-leucovorin (l-LV) on modified Roswell Park regimen as first-line treatment of advanced colorectal cancer (ACRC): A phase I/II study

12. 735 L-Leucovorin (LLV) as a modulator of 5-days 5-fluorouracil (5FU) in advanced colorectal cancer (ACC): High dose (HD) versus low dose (LD)

Catalog

Books, media, physical & digital resources